Startseite

Aktien

Metagenomi

Nachrichten

Metagenomi Aktie

Aktie

ISIN: US59102M1045 WKN: A4021A SYM: MGX Land Flagge US

USA

Zur Watchlist hinzufügen Zum Portfolio hinzufügen

Zum Portfolio hinzufügen

1,7050

USD

-2,57 %

-0,0450 USD

Letzter Kurs 21:27:16 Nasdaq

Metagenomi Aktie kaufen

Geldkurs

21:20:07

1,7000

USD

1.100 STK

Briefkurs

21:20:07

1,7100

USD

900 STK

Verkauf

Kauf

Hinweis
Verlängerte Handelszeiten
Ab sofort von 07:30 bis 23:00 Uhr

Neueste Nachrichten

Metagenomi Announces Corporate Name Change to Metagenomi Therapeutics, Inc. and Highlights Recent Business Milestones and 2026 Corporate Outlook 12.01.26 · globenewswire · Metagenomi
Metagenomi to Present Preclinical Data Supporting New Collaboration Target of APOC3 with Ionis Pharmaceuticals at Upcoming Nature Conference 01.12.25 · globenewswire · Metagenomi
Metagenomi to Present at Jefferies Global Healthcare Conference in London 17.11.25 · globenewswire · Metagenomi
Metagenomi Reports Third Quarter 2025 Financial Results and Announces Strategic Pipeline Prioritization and Leadership Updates 11.11.25 · globenewswire · Metagenomi
Metagenomi Presents New Preclinical Data from MGX-001 Hemophilia A Program Supporting Advancement into Clinical Development 11.11.25 · globenewswire · Metagenomi
Metagenomi Reports Business Updates and Second Quarter 2025 Financial Results 12.08.25 · globenewswire · Metagenomi
Metagenomi Appoints Laurence Reid, PhD to its Board of Directors 11.08.25 · globenewswire · Metagenomi
Metagenomi Presents Data Highlighting Advancements in Next-Generation Genome Editing Technologies at ASGCT Annual Meeting 2025 14.05.25 · globenewswire · Metagenomi
Metagenomi Reports Business Updates and First Quarter 2025 Financial Results 13.05.25 · globenewswire · Metagenomi
Metagenomi to Present at Upcoming Scientific Meetings 02.05.25 · globenewswire · Metagenomi
Metagenomi Reports Business Updates and Full Year 2024 Financial Results 17.03.25 · globenewswire · Metagenomi
Metagenomi Announces Publication in Nature Communications on Large Gene Integration Advances Using Novel, Compact CRISPR-associated transposase (CAST) Systems 13.03.25 · globenewswire · Metagenomi

1
2

Metagenomi Announces Corporate Name Change to Metagenomi Therapeutics, Inc. and Highlights Recent ... 112 Leser

Metagenomi Reports Business Updates and Full Year 2024 Financial Results 212 Leser
Metagenomi to Present at TD Cowen's 45th Annual Health Care Conference 200 Leser
Metagenomi Announces Publication in Nature Communications on Large Gene Integration Advances Using ... 160 Leser
Metagenomi Presents Data Highlighting Advancements in Next-Generation Genome Editing Technologies ... 140 Leser
Metagenomi Reports Third Quarter 2025 Financial Results and Announces Strategic Pipeline ... 136 Leser
Metagenomi Reports Business Updates and First Quarter 2025 Financial Results 128 Leser
Metagenomi to Present at Jefferies Global Healthcare Conference in London 128 Leser
Metagenomi to Present at Upcoming Scientific Meetings 124 Leser
Metagenomi to Present Preclinical Data Supporting New Collaboration Target of APOC3 with Ionis ... 124 Leser
Metagenomi Reports Business Updates and Second Quarter 2025 Financial Results 120 Leser